Altamont Pharma Acquisition Corp. (ALTP)

Altamont Pharma Acquisition will go public soon, but the exact IPO date is still unknown.
Stock Price: $10.00
Confirmed IPO price
Chart not available yet
Data will show when the stock starts trading.
Market Cap 125.00M
Revenue (ttm) n/a
Net Income (ttm) n/a
Shares Out 12.50M
EPS (ttm) n/a
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume n/a
Open n/a
Previous Close n/a
Day's Range n/a
52-Week Range n/a
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date n/a

About ALTP

Altamont Pharma Acquisition is a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. It is our intention to pursue prospective targets that are focused on healthcare innovation. We anticipate targeting companies domiciled in North America or Europe that are developing assets in the biopharma and medical technology sectors, which aligns with our management team’s experience in healthcare investing and dru... [Read more...]

Industry Blank Check / SPAC
Founded 2021
CEO Mark Pearson
Country United States
Stock Exchange NASDAQ
Ticker Symbol ALTP
Full Company Profile


Healthcare SPAC Altamont Pharma Acquisition files for a $100 million IPO

Altamont Pharma Acquisition, a blank check company targeting the biopharma and medical technology sectors, filed on Tuesday with the SEC to raise up to $100 million in an initial public offering.

Altamont Pharma Acquisition IPO Registration Document (S-1)

Altamont Pharma Acquisition Corp. has filed to go public with an IPO on the NASDAQ.